Literature DB >> 17404870

Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease.

Soichi Itaba1, Tsutomu Iwasa, Yojiro Sadamoto, Toshifumi Nasu, Tadashi Misawa, Koji Inoue, Hidehiko Shimokawa, Kazuhiko Nakamura, Ryoichi Takayanagi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17404870     DOI： 10.1007/s10620-006-9575-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  26 in total

Review 1.  Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.

Authors:  Nirmal Kaur; Thomas C Mahl
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

2.  An unusual complication of immunosuppressive therapy in inflammatory bowel disease.

Authors:  M Khatchatourian; T L Seaton
Journal:  Am J Gastroenterol       Date:  1997-09       Impact factor: 10.864

3.  Infliximab in Crohn's disease: first anniversary clinical experience.

Authors:  R D Cohen; J F Tsang; S B Hanauer
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

Review 4.  Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome.

Authors:  Kent A Sepkowitz
Journal:  Clin Infect Dis       Date:  2002-03-21       Impact factor: 9.079

Review 5.  Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk.

Authors:  K A Sepkowitz; A E Brown; D Armstrong
Journal:  Arch Intern Med       Date:  1995-06-12

Review 6.  Review article: the management of refractory Crohn's disease.

Authors:  F Rizzello; P Gionchetti; A Venturi; C Morselli; M Campieri
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

Review 7.  Pneumocystis carinii infection. Update and review.

Authors:  Javed F Wazir; Naseem A Ansari
Journal:  Arch Pathol Lab Med       Date:  2004-09       Impact factor: 5.534

8.  Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease.

Authors:  K Ewe; A G Press; C C Singe; M Stufler; B Ueberschaer; G Hommel; K H Meyer zum Büschenfelde
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

9.  The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

Authors:  Jean-Frederic Colombel; Edward V Loftus; William J Tremaine; Laurence J Egan; W Scott Harmsen; Cathy D Schleck; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

Review 10.  A new name (Pneumocystis jiroveci) for Pneumocystis from humans.

Authors:  James R Stringer; Charles B Beard; Robert F Miller; Ann E Wakefield
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883
View more
  5 in total

1.  Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.

Authors:  Thomas G Cotter; Nicola Gathaiya; Jelena Catania; Edward V Loftus; William J Tremaine; Larry M Baddour; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn; Andrew H Limper; Darrell S Pardi
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-21       Impact factor: 11.382

2.  B cell production of tumor necrosis factor in response to Pneumocystis murina infection in mice.

Authors:  Michael M Opata; Zhan Ye; Melissa Hollifield; Beth A Garvy
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

3.  Biofilm formation by Pneumocystis spp.

Authors:  Melanie T Cushion; Margaret S Collins; Michael J Linke
Journal:  Eukaryot Cell       Date:  2008-09-26

4.  Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.

Authors:  Sally J Lawrence; Manish Sadarangani; Kevan Jacobson
Journal:  Front Pediatr       Date:  2017-07-24       Impact factor: 3.418

5.  Increased dosage of infliximab is a potential cause of Pneumocystis carinii pneumonia.

Authors:  Takuya Iwama; Aki Sakatani; Mikihiro Fujiya; Kazuyuki Tanaka; Shugo Fujibayashi; Yoshiki Nomura; Nobuhiro Ueno; Shin Kashima; Takuma Gotoh; Junpei Sasajima; Kentaro Moriichi; Katsuya Ikuta
Journal:  Gut Pathog       Date:  2016-02-02       Impact factor: 4.181
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.